Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

November 29 2023 - FDA names chief scientist Bumpus as Woodcock’s successor

FDA names chief scientist Bumpus as Woodcock’s successor
FDA launches probe of malignancies linked to CAR-T therapies
FDA kicks off review of Karuna’s schizophrenia drug KarXT
Lilly puts potential $660M on the line for protein-protein interaction blockers
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst

Fierce Pharma

Tuesday, November 21, 2023 - 10:43pm

tags:

Bayer, Pharma CEOs, Bill Anderson, asundexian

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program

Fierce Pharma

Tuesday, November 21, 2023 - 10:40pm

tags:

Pfizer, Tris Pharma, ADHD, Texas, Medicaid

GSK says new inhaler will help slash its carbon footprint

Pharmaphorum

Tuesday, November 21, 2023 - 10:39pm

tags:

GSK, inhalers, carbon emisssions, sustainability

Merck Drops Up to $610M on Neuro Disease-Focused Caraway Therapeutics

BioSpace

Tuesday, November 21, 2023 - 12:05pm

tags:

Merck, M&A, neurodegenerative disease, Caraway Therapeutics

Almirall and Absci partnership will help deliver life-changing medicines

Outsourcing Pharma

Tuesday, November 21, 2023 - 12:03pm

tags:

Almirall, Absci, dermatology, drug development

Roche’s Genentech partners with Nvidia in AI drug deal

BioPharma Dive

Tuesday, November 21, 2023 - 12:00pm

tags:

Roche, Genentech, artificial intelligence, NVIDIA

NeoImmuneTech receives orphan drug status for NT-I7 to treat ARS

Pharmaceutical Business Review

Tuesday, November 21, 2023 - 11:59am

tags:

NeoImmune Tech, FDA, NT-I7, acute radiation syndrome, orphan drugs

MorphoSys’ pelabresib meets endpoints in Phase III myelofibrosis trial

Clinical Trials Arena

Tuesday, November 21, 2023 - 11:55am

tags:

MorphoSys, clinical trials, pelabresib, myelofibrosis

BeiGene Inks Potential $1.3B Deal with Ensem for Early-Stage CDK2 Inhibitor

BioSpace

Tuesday, November 21, 2023 - 11:54am

tags:

BeiGene, Ensem, EXT-197, cancer

Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug

BioPharma Dive

Tuesday, November 21, 2023 - 11:45am

tags:

Biohaven, weightloss, Ozempic, Wegovy

AstraZeneca’s Imfinzi Phase III trial raises trial design questions

Clinical Trials Arena

Tuesday, November 21, 2023 - 11:41am

tags:

AstraZeneca, Imfinzi, clinical trials

European Patent Office declares Moderna mRNA patent invalid

Reuters

Tuesday, November 21, 2023 - 11:39am

tags:

Moderna Therapeutics, MRNA, patents, BioNTech, Pfizer, vaccines, Europe

Teva granted pretrial appeal in high-stakes Copaxone kickbacks case

Fierce Pharma

Tuesday, November 21, 2023 - 11:23am

tags:

Teva Pharmaceutical, Copaxone, legal, kickbacks

Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of RSV antibody Beyfortus

Fierce Pharma

Monday, November 20, 2023 - 9:38pm

tags:

Sanofi, AstraZeneca, Senate, CDC, RSV, Beyfortus, drug shortages

Gilead Oncology’s brand refresh takes back the possibilities cancer steals

Medical Marketing and Media

Monday, November 20, 2023 - 9:36pm

tags:

Gilead Oncology, branding, oncology, cancer

Medtronic Finally Wins the Big One for Symplicity RDN Treatment

Medical Devices and Diagnostics Industry

Monday, November 20, 2023 - 9:32pm

tags:

Medtronic, Medtech, Symplicity, FDA, renal denervation, hypertension

Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast

Fierce Biotech

Monday, November 20, 2023 - 11:41am

tags:

Bayer, asundexian, bloodthinners, Eliquis, clinical trials

The Next Generation of Weight Loss Drugs is Rapidly Approaching

BioSpace

Monday, November 20, 2023 - 11:32am

tags:

weightloss, Novo Nordisk, Eli Lilly, Pfizer, AstraZeneca, Wegovy, Zepbound

Q3 recap: Medtech firms grapple with layoffs, GLP-1s and China slowdown

Medtech Dive

Monday, November 20, 2023 - 11:30am

tags:

Medtech, earnings, inflation, China, layoffs

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

Fierce Pharma

Monday, November 20, 2023 - 11:28am

tags:

UK, drug pricing, NHS

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels

Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup

Drug Channels